Cargando…

Silymarin: An option to treat non-alcoholic fatty liver disease

We have read with a great interest the review published by Singh et al, on the treatment options in alcoholic and non-alcoholic fatty liver disease, including various new targeted therapies that are currently under investigation. Recently, we described the health effects of the Mediterranean diet as...

Descripción completa

Detalles Bibliográficos
Autores principales: Colica, Carmela, Boccuto, Luigi, Abenavoli, Ludovico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743515/
https://www.ncbi.nlm.nih.gov/pubmed/29309065
http://dx.doi.org/10.3748/wjg.v23.i47.8437
_version_ 1783288581810290688
author Colica, Carmela
Boccuto, Luigi
Abenavoli, Ludovico
author_facet Colica, Carmela
Boccuto, Luigi
Abenavoli, Ludovico
author_sort Colica, Carmela
collection PubMed
description We have read with a great interest the review published by Singh et al, on the treatment options in alcoholic and non-alcoholic fatty liver disease, including various new targeted therapies that are currently under investigation. Recently, we described the health effects of the Mediterranean diet associated to an antioxidant complex rich in silymarin, to improve in overweight patients anthropometric parameters, glucose and lipid metabolism and intra-hepatic fat accumulation.
format Online
Article
Text
id pubmed-5743515
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-57435152018-01-05 Silymarin: An option to treat non-alcoholic fatty liver disease Colica, Carmela Boccuto, Luigi Abenavoli, Ludovico World J Gastroenterol Letters To The Editor We have read with a great interest the review published by Singh et al, on the treatment options in alcoholic and non-alcoholic fatty liver disease, including various new targeted therapies that are currently under investigation. Recently, we described the health effects of the Mediterranean diet associated to an antioxidant complex rich in silymarin, to improve in overweight patients anthropometric parameters, glucose and lipid metabolism and intra-hepatic fat accumulation. Baishideng Publishing Group Inc 2017-12-21 2017-12-21 /pmc/articles/PMC5743515/ /pubmed/29309065 http://dx.doi.org/10.3748/wjg.v23.i47.8437 Text en ©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Letters To The Editor
Colica, Carmela
Boccuto, Luigi
Abenavoli, Ludovico
Silymarin: An option to treat non-alcoholic fatty liver disease
title Silymarin: An option to treat non-alcoholic fatty liver disease
title_full Silymarin: An option to treat non-alcoholic fatty liver disease
title_fullStr Silymarin: An option to treat non-alcoholic fatty liver disease
title_full_unstemmed Silymarin: An option to treat non-alcoholic fatty liver disease
title_short Silymarin: An option to treat non-alcoholic fatty liver disease
title_sort silymarin: an option to treat non-alcoholic fatty liver disease
topic Letters To The Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743515/
https://www.ncbi.nlm.nih.gov/pubmed/29309065
http://dx.doi.org/10.3748/wjg.v23.i47.8437
work_keys_str_mv AT colicacarmela silymarinanoptiontotreatnonalcoholicfattyliverdisease
AT boccutoluigi silymarinanoptiontotreatnonalcoholicfattyliverdisease
AT abenavoliludovico silymarinanoptiontotreatnonalcoholicfattyliverdisease